Feds Allow Experimental Cancer Trial to Resume Despite Recent Deaths
Just days after shutting down psychometric test of a groundbreaking new cancer therapy in the wake of three patient role deaths , the US Food and Drug Administration has said the trials can resume . So what changed ? Late last workweek , it wasreportedthat three cancer of the blood patients had died in a Juno Therapeutics Phase II clinical trial that ’s assessinga revolutionary novel therapy , predict JCAR015 , that use genetically organize immune cells to treat Cancer the Crab ....